Last week saw the biggest event on the international MS research calendar, the 2015 European Committee for Treatment

MS results from the loss of myelin, the insulating coating of nerve fibres, in the brain and spinal

Genentech, a biotechnology company owned by Roche Pharmaceuticals, has announced promising results from a phase III clinical trial

Since 2008 people with MS have been able to make a very special gift to MS research by

During the week of 7 – 13 September, MS Research Australia, Include a Charity and 140 other charities

During September, MS Research Australia and over 140 other charities across Australia, will be working together with the

MS is thought to be caused by a person’s own immune system mistakenly attacking components of the brain

New Australian research has identified that over half of the risk factors related to developing MS are environmental

The most recent round of incubator grants were awarded in July. These smaller grants are awarded to investigate